JP2022501315A5 - - Google Patents
Info
- Publication number
- JP2022501315A5 JP2022501315A5 JP2021506258A JP2021506258A JP2022501315A5 JP 2022501315 A5 JP2022501315 A5 JP 2022501315A5 JP 2021506258 A JP2021506258 A JP 2021506258A JP 2021506258 A JP2021506258 A JP 2021506258A JP 2022501315 A5 JP2022501315 A5 JP 2022501315A5
- Authority
- JP
- Japan
- Prior art keywords
- benzamide
- diethylamino
- ethyl
- compound
- formula
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18189194 | 2018-08-15 | ||
| EP18189194.6 | 2018-08-15 | ||
| PCT/EP2019/071903 WO2020035554A1 (en) | 2018-08-15 | 2019-08-15 | A new medical treatment for pathologic inflammation |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022501315A JP2022501315A (ja) | 2022-01-06 |
| JPWO2020035554A5 JPWO2020035554A5 (https=) | 2022-08-17 |
| JP2022501315A5 true JP2022501315A5 (https=) | 2022-08-17 |
| JP7512251B2 JP7512251B2 (ja) | 2024-07-08 |
Family
ID=63294023
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021506258A Active JP7512251B2 (ja) | 2018-08-15 | 2019-08-15 | 病的炎症の新しい医療 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11896564B2 (https=) |
| EP (1) | EP3836912B1 (https=) |
| JP (1) | JP7512251B2 (https=) |
| CN (1) | CN112770736B (https=) |
| AU (1) | AU2019322564A1 (https=) |
| BR (1) | BR112021001984A2 (https=) |
| CA (1) | CA3108361A1 (https=) |
| IL (1) | IL280548A (https=) |
| MX (1) | MX2021001349A (https=) |
| WO (1) | WO2020035554A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112703036B (zh) * | 2018-08-15 | 2025-05-27 | 法玛西尔有限公司 | 取代的苯甲酰胺及其在疗法中的用途 |
| US11717500B2 (en) * | 2020-02-03 | 2023-08-08 | Pharmacyl Ab | Treatment of spondyloarthritis |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL281394A (https=) | 1961-07-25 | |||
| US6028111A (en) | 1996-03-08 | 2000-02-22 | Oxigene, Inc. | Compositions and use of benzamides and nicotinamides as anti-inflammatory agents |
| US6100299A (en) | 1996-03-08 | 2000-08-08 | Oxigene, Inc. | N-acetyl 3-chloroprocainamide, acid addition salts thereof, and methods of use |
| US6518312B2 (en) | 2000-07-05 | 2003-02-11 | Active Biotech Ab | Immune enhancement |
| US7157444B2 (en) | 2002-12-21 | 2007-01-02 | Deanna Jean Nelson | Aminosalicylate derivatives for treatment of inflammatory bowel disease |
| WO2005025498A2 (en) | 2003-09-08 | 2005-03-24 | Corus Pharma | Substituted acetanilides and benzamides for the treatment of asthma and pulmonary inflammation |
| SE0400235D0 (sv) | 2004-02-06 | 2004-02-06 | Active Biotech Ab | New composition containing quinoline compounds |
| DE102004011720B4 (de) | 2004-03-10 | 2008-04-03 | Bayer Schering Pharma Aktiengesellschaft | Radiohalogenierte Benzamidderivate und deren Verwendung in der Tumordiagnostik und Tumortherapie |
| CA2649256C (en) * | 2006-04-13 | 2013-09-10 | Taiho Pharmaceutical Co., Ltd. | Therapeutic agent for inflammatory bowel disease |
| RU2469724C2 (ru) * | 2007-12-18 | 2012-12-20 | Мейдзи Сейка Фарма Ко., Лтд. | Профилактическое или терапевтическое вещество при воспалительных болезнях кишечника |
| WO2018037103A1 (en) * | 2016-08-26 | 2018-03-01 | Idogen Ab | Procainamide for treating immune disorders and for modulating ido expression |
-
2019
- 2019-08-15 WO PCT/EP2019/071903 patent/WO2020035554A1/en not_active Ceased
- 2019-08-15 CA CA3108361A patent/CA3108361A1/en active Pending
- 2019-08-15 EP EP19750131.5A patent/EP3836912B1/en active Active
- 2019-08-15 CN CN201980051160.XA patent/CN112770736B/zh active Active
- 2019-08-15 US US17/264,924 patent/US11896564B2/en active Active
- 2019-08-15 JP JP2021506258A patent/JP7512251B2/ja active Active
- 2019-08-15 MX MX2021001349A patent/MX2021001349A/es unknown
- 2019-08-15 BR BR112021001984-7A patent/BR112021001984A2/pt not_active IP Right Cessation
- 2019-08-15 AU AU2019322564A patent/AU2019322564A1/en not_active Abandoned
-
2021
- 2021-02-01 IL IL280548A patent/IL280548A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20120505T1 (hr) | Supstituirani n fenilmetil oksoprolin amidi kao antagonisti receptora p x i postupci njihove upotrebe | |
| HRP20170638T1 (hr) | MODULATORI RETINOIDNIMA SRODNOG SIROČETA RECEPTORA γ (ROR-γ), NAMIJENJENI UPOTREBI U LIJEČENJU AUTOIMUNIH I PROTUUPALNIH BOLESTI | |
| HRP20241768T1 (hr) | Heterociklički spoj | |
| JP2017537940A5 (https=) | ||
| HRP20210726T1 (hr) | Ciklički dinukleotidi kao antagonisti sting (stimulatora interferonskih gena) | |
| HRP20240157T1 (hr) | Deuterirani derivati lanifibranora | |
| JP2017523225A5 (https=) | ||
| JP2018533593A5 (https=) | ||
| JP2015024998A5 (https=) | ||
| JP2014502979A5 (https=) | ||
| JP2010524947A5 (https=) | ||
| HRP20090577T8 (en) | Use of crth2 antagonist compounds in therapy | |
| SI2743266T1 (en) | Protein kinase inhibitors (variants), their use in the treatment of oncological diseases and the pharmaceutical composition on their basis | |
| JP2020502047A5 (https=) | ||
| JP2014062126A5 (https=) | ||
| JP2015535847A5 (https=) | ||
| RU2015121424A (ru) | Комбинированная терапия | |
| JP2017504595A5 (https=) | ||
| JP2019531279A5 (https=) | ||
| RU2017101829A (ru) | Пиразоловые соединения в качестве модуляторов fshr и пути их применения | |
| HRP20241558T1 (hr) | Dvojni inhibitori magl i faah | |
| JP2015508068A5 (https=) | ||
| JP2022501315A5 (https=) | ||
| RU2010115337A (ru) | Трициклические гетероциклические производные | |
| RU2009102270A (ru) | Производные тиазолилмочевины в качестве ингибиторов фосфатидилинозитол-3-киназы |